GT Biopharma (GTBP) Institutional Ownership $1.07 -0.01 (-0.93%) Closing price 08/21/2025 04:00 PM EasternExtended Trading$1.05 -0.02 (-1.50%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for GT Biopharma (NASDAQ:GTBP)CurrentInstitutional OwnershipPercentage8.15%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$278.81KNumber ofInstitutional Sellers(last 12 months)0 Get GTBP Insider Trade Alerts Want to know when executives and insiders are buying or selling GT Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GTBP Institutional Buying and Selling by Quarter GT Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/5/2025 Bank of Montreal Can92,530$331K0.0%+531.6%2.830% 8/8/2024 DekaBank Deutsche Girozentrale978,358$2.77M0.0%-10.5%69.044% 6/4/2024 DekaBank Deutsche Girozentrale1,093,645$47.45M0.1%N/A77.017% 8/2/2023 Bank of Montreal Can596,240$262K0.0%N/A1.596% 1/23/2023 Baskin Financial Services Inc.151,354$134K0.0%N/A0.466% 11/7/2022 Virtu Financial LLC24,864$44K0.0%N/A0.076% 5/5/2022 Russell Investments Group Ltd.11,007$31K0.0%N/A0.033% 5/2/2022 Allspring Global Investments Holdings LLC25,782$74K0.0%N/A0.078% 4/20/2022 Sigma Planning Corp21,400$62K0.0%N/A0.067% 2/14/2022 Gordian Capital Singapore Pte Ltd35,000$107K0.1%N/A0.114% Get the Latest News and Ratings for GTBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GT Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/9/2022 Compagnie Lombard Odier SCmA30,000$92K0.0%+100.0%0.098% 2/4/2022 Crumly & Associates Inc.32,163$85K0.0%N/A0.105% 2/3/2022 Brighton Jones LLC11,288$34K0.0%N/A0.037% 1/31/2022 Commonwealth Equity Services LLC11,052$33K0.0%N/A0.036% 11/16/2021 Two Sigma Advisers LP51,100$344K0.0%+243.0%0.242% 11/16/2021 Two Sigma Investments LP162,823$1.10M0.0%N/A0.771% 11/15/2021 Marshall Wace LLP16,577$112K0.0%-35.7%0.078% 11/15/2021 Franklin Resources Inc.28,500$192K0.0%N/A0.135% 11/12/2021 Renaissance Technologies LLC84,700$571K0.0%N/A0.401% 11/12/2021 Geode Capital Management LLC424,279$2.86M0.0%+22.4%2.008% 11/10/2021 Goldman Sachs Group Inc.52,426$353K0.0%N/A0.248% 11/9/2021BlackRock Inc.1,155,228$7.79M0.0%-18.3%5.468% 11/8/2021 State Board of Administration of Florida Retirement System18,224$123K0.0%N/A0.086% 11/8/2021 Russell Investments Group Ltd.9,642$64K0.0%N/A0.046% 11/5/2021 Welch Group LLC10,000$67K0.0%N/A0.047% 11/4/2021 Deutsche Bank AG11,400$77K0.0%-25.7%0.054% 11/2/2021 New York State Common Retirement Fund8,230$55K0.0%-59.7%0.039% 8/25/2021 Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/17/2021 Metropolitan Life Insurance Co NY8,782$136K0.0%N/A0.042% 8/17/2021 MetLife Investment Management LLC11,471$178K0.0%N/A0.054% 8/17/2021 Citadel Advisors LLC510,058$7.91M0.0%N/A2.414% 8/16/2021 California State Teachers Retirement System32,878$510K0.0%N/A0.156% 8/16/2021 Charles Schwab Investment Management Inc.57,993$899K0.0%N/A0.274% 8/16/2021 State Street Corp374,704$5.81M0.0%N/A1.773% 8/16/2021Nuveen Asset Management LLC82,151$1.27M0.0%N/A0.389% 8/16/2021 Marshall Wace LLP25,792$400K0.0%N/A0.122% 8/13/2021 Northern Trust Corp225,457$3.50M0.0%+555.6%1.067% 8/13/2021 Geode Capital Management LLC346,606$5.37M0.0%+165.8%1.641% 8/13/2021 Vanguard Group Inc.982,269$15.23M0.0%+267.0%4.649% 8/12/2021 Legal & General Group Plc2,524$39K0.0%N/A0.012% One tiny company just cracked Google’s $19B problem (Ad)Google’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new research from Northwestern shows a breakthrough material can cut chip energy use by up to 99%, saving Google an estimated $19 billion annually. Only one small U.S. company produces this material—just 30 metric tons a year from its Texas facility—and it could be the most important upgrade in AI history.Click here to see the sub-$20 stock behind this breakthrough.8/12/2021 JPMorgan Chase & Co.9,155$142K0.0%N/A0.043% 8/12/2021 The Manufacturers Life Insurance Company13,758$213K0.0%N/A0.065% 8/11/2021 Bank of New York Mellon Corp58,711$910K0.0%N/A0.278% 8/11/2021BlackRock Inc.1,413,391$21.91M0.0%N/A6.690% 8/11/2021 Deutsche Bank AG15,349$237K0.0%N/A0.073% 8/10/2021 Citigroup Inc.6,134$95K0.0%N/A0.029% 8/6/2021 Ameritas Investment Partners Inc.1,870$29K0.0%N/A0.009% 8/5/2021 Rhumbline Advisers18,634$289K0.0%N/A0.088% 8/2/2021 New York State Common Retirement Fund20,400$316K0.0%N/A0.097% 8/2/2021 Advisor Group Holdings Inc.2,943$45K0.0%+108.3%0.014% 5/18/2021 Millennium Management LLC27,895$191K0.0%N/A0.098% 5/17/2021 Royal Bank of Canada24,542$167K0.0%N/A0.086% (Data available from 1/1/2016 forward) GTBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GTBP shares? During the previous two years, the following institutional investors and hedge funds held shares of GT Biopharma shares: DekaBank Deutsche Girozentrale ($2.77M), Bank of Montreal Can ($331K).Learn more on GT Biopharma's institutional investors. What percentage of GT Biopharma's stock is owned by institutional investors? 8.15% of GT Biopharma's stock is owned by institutional investors. Learn more on GTBP's institutional investor holdings. Which institutional investors have been buying GT Biopharma's stock? The following institutional investors have purchased GT Biopharma's stock in the last 24 months: DekaBank Deutsche Girozentrale ($1.09M), and Bank of Montreal Can ($77.88K). How much institutional buying is happening at GT Biopharma? Institutional investors have bought a total of 77,879 shares in the last 24 months. This purchase volume represents approximately $278.81K in transactions. Related Companies MIRA Pharmaceuticals Major Shareholders Natural Alternatives International Major Shareholders Cadrenal Therapeutics Major Shareholders Lisata Therapeutics Major Shareholders Rallybio Major Shareholders Cingulate Major Shareholders Elevation Oncology Major Shareholders Aytu BioPharma Major Shareholders BioAtla Major Shareholders Adaptimmune Therapeutics Major Shareholders This page (NASDAQ:GTBP) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.